— Know what they know.
Not Investment Advice

MYOV NYSE

Myovant Sciences Ltd.
1W: +0.1% 1M: +0.3% 3M: +0.3% 1Y: +137.1% 3Y: +173.6% 5Y: +68.6%
$26.98
Last traded 2023-03-09 — delisted
NYSE · Healthcare · Biotechnology · $2.6B mcap · 51M float · 2.21% daily turnover

Balance Sheet Trends

Total Assets
$520M -28.3% ▼
5Y CAGR: +22.9%
Total Liabilities
$993M -7.9% ▼
5Y CAGR: +121.8%
Shareholders Equity
-$473M -33.8% ▼
Cash & Investments
$434M -36.6% ▼
5Y CAGR: +19.1%
Total Debt
$368M -0.5% ▼
Net Debt
-$39M +87.3% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$109M$156M$77M$674M$407M
Short-Term Investments$0$0$3M$10M$27M
Cash & ST Investments$109M$156M$80M$685M$434M
Net Receivables$0$0$0$4M$23M
Inventory$0$0$0$3M$8M
Other Current Assets$6M$11M$8M$14M$23M
Total Current Assets$115M$167M$88M$705M$488M
Property, Plant & Equip.$1M$2M$14M$13M$11M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$3M$4M$4M$7M$21M
Total Non-Current Assets$4M$6M$18M$20M$32M
Total Assets$119M$173M$106M$725M$520M
— Liabilities —
Accounts Payable$5M$15M$15M$18M$12M
Short-Term Debt$0$6M$2M$2M$2M
Deferred Revenue$0$0$40M$193M$135M
Other Current Liabilities$33M$55M$29M$161M$135M
Total Current Liabilities$37M$72M$86M$281M$250M
Long-Term Debt$44M$93M$125M$368M$366M
Other Non-Current Liab.$663K$3M$4M$32M$2M
Total Non-Current Liabilities$44M$97M$128M$798M$743M
Total Liabilities$81M$169M$214M$1.1B$993M
— Equity —
Common Stock$1K$1K$2K$2K$2K
Retained Earnings-$228M-$502M-$791M-$1.0B-$1.3B
Accumulated OCI$24K$507K-$2M-$17M-$17M
Total Stockholders Equity$38M$4M-$108M-$354M-$473M
Total Liabilities & Equity$119M$173M$106M$725M$520M
— Key Metrics —
Total Debt$44M$99M$126M$370M$368M
Net Debt-$65M-$57M$50M-$305M-$39M
Total Investments$0$0$3M$10M$27M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms